Business Context and Reporting Period
This Form 8-K was filed by iSpecimen Inc. (ISPC) on October 10, 2023, reporting an event that occurred on October 9, 2023. The company is a Delaware corporation with its principal executive offices in Lexington, MA, and its common stock trades on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory compliance matter regarding the company's stock listing status.
Material Changes
On October 9, 2023, the Company received a deficiency notice from The Nasdaq Stock Market. The notice states that the Company's common stock failed to comply with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). This failure was based on the closing bid price for the 30 consecutive business days prior to the notice date.
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has been granted an initial compliance period of 180 calendar days, ending April 8, 2024, to regain compliance.
- Requirements: To regain compliance, the closing bid price must meet or exceed $1.00 per share for a minimum of ten consecutive business days prior to April 8, 2024.
- Future Options: If the Company fails to regain compliance by the initial deadline, it may be eligible for an additional 180-day period. Qualifying for this second period requires meeting all other initial listing standards (excluding bid price) and may necessitate a reverse stock split.
- Delisting Risk: Failure to qualify for or succeed in the second compliance period could result in a determination to delist the Common Stock, subject to an appeal process.
- Management Action: Management intends to monitor the stock price and may consider implementing available options, including a reverse stock split, to regain compliance.
Investor Verification Checklist
- Verify the current closing bid price of ISPC stock relative to the $1.00 threshold.
- Monitor for any announcements regarding a reverse stock split or other capital structure changes.
- Track the Company's progress toward the April 8, 2024, compliance deadline.
- Review subsequent filings for updates on the deficiency notice or potential delisting appeals.